UHRF1 Induces Methylation of the TXNIP Promoter and Down-Regulates Gene Expression in Cervical Cancer |
Kim, Min Jun
(Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University)
Lee, Han Ju (Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University) Choi, Mee Young (Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University) Kang, Sang Soo (Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University) Kim, Yoon Sook (Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University) Shin, Jeong Kyu (Department of Obstetrics and Gynecology, College of Medicine, Gyeongsang National University) Choi, Wan Sung (Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University) |
1 | Jiao, D., Huan, Y., Zheng, J., Wei, M., Zheng, G., Han, D., Wu, J., Xi, W., Wei, F., Yang, A.G., et al. (2019). UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP. Oncogene 38, 5686-5699. DOI |
2 | Kaimul, A.M., Nakamura, H., Masutani, H., and Yodoi, J. (2007). Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 43, 861-868. DOI |
3 | Lindner, H.A. (2007). Deubiquitination in virus infection. Virology 362, 245-256. DOI |
4 | Liu, Y. and Min, W. (2002). Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ. Res. 90, 1259-1266. DOI |
5 | Morrison, J.A., Pike, L.A., Sams, S.B., Sharma, V., Zhou, Q., Severson, J.J., Tan, A.C., Wood, W.M., and Haugen, B.R. (2014). Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer. Mol. Cancer 13, 62. DOI |
6 | Nie, W., Huang, W., Zhang, W., Xu, J., Song, W., Wang, Y., Zhu, A., Luo, J., Huang, G., Wang, Y., et al. (2015). TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer. Oncotarget 6, 3003-3012. DOI |
7 | Poreba, E., Broniarczyk, J.K., and Gozdzicka-Jozefiak, A. (2011). Epigenetic mechanisms in virus-induced tumorigenesis. Clin. Epigenetics 2, 233-247. DOI |
8 | Pyeon, D., Newton, M.A., Lambert, P.F., den Boon, J.A., Sengupta, S., Marsit, C.J., Woodworth, C.D., Connor, J.P., Haugen, T.H., Smith, E.M., et al. (2007). Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67, 4605-4619. DOI |
9 | Rhodes, D.R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A.M. (2004). ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6. DOI |
10 | Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606. DOI |
11 | Sharif, J., Muto, M., Takebayashi, S., Suetake, I., Iwamatsu, A., Endo, T.A., Shinga, J., Mizutani-Koseki, Y., Toyoda, T., Okamura, K., et al. (2007). The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908-912. DOI |
12 | Wan, X., Yang, S., Huang, W., Wu, D., Chen, H., Wu, M., Li, J., Li, T., and Li, Y. (2016). UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy. J. Exp. Clin. Cancer Res. 35, 34. DOI |
13 | Sheng, Y., Wang, H., Liu, D., Zhang, C., Deng, Y., Yang, F., Zhang, T., and Zhang, C. (2016). Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma. Gynecol. Oncol. 140, 145-151. DOI |
14 | Unoki, M., Kelly, J.D., Neal, D.E., Ponder, B.A., Nakamura, Y., and Hamamoto, R. (2009). UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br. J. Cancer 101, 98-105. DOI |
15 | Unoki, M., Nishidate, T., and Nakamura, Y. (2004). ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23, 7601-7610. DOI |
16 | Wei, M., Jiao, D., Han, D., Wu, J., Wei, F., Zheng, G., Guo, Z., Xi, W., Yang, F., Xie, P., et al. (2017). Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP. Oncotarget 8, 5323-5338. DOI |
17 | Welsh, S.J., Bellamy, W.T., Briehl, M.M., and Powis, G. (2002). The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62, 5089-5095. |
18 | Esteller, M. (2008). Epigenetics in cancer. N. Engl. J. Med. 358, 1148-1159. DOI |
19 | Elgort, M.G., O'Shea, J.M., Jiang, Y., and Ayer, D.E. (2010). Transcriptional and translational downregulation of thioredoxin interacting protein is required for metabolic reprogramming during G(1). Genes Cancer 1, 893-907. DOI |
20 | Erkeland, S.J., Palande, K.K., Valkhof, M., Gits, J., Danen-van Oorschot, A., and Touw, I.P. (2009). The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients. Leuk. Res. 33, 1367-1371. DOI |
21 | Felle, M., Joppien, S., Nemeth, A., Diermeier, S., Thalhammer, V., Dobner, T., Kremmer, E., Kappler, R., and Langst, G. (2011). The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res. 39, 8355-8365. DOI |
22 | Ge, T.T., Yang, M., Chen, Z., Lou, G., and Gu, T. (2016). UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells. J. Ovarian Res. 9, 42. DOI |
23 | Zhang, Q., Qiao, L., Wang, X., Ding, C., and Chen, J.J. (2018). UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells. Cell Cycle 17, 300-308. DOI |
24 | Alhosin, M., Sharif, T., Mousli, M., Etienne-Selloum, N., Fuhrmann, G., Schini-Kerth, V.B., and Bronner, C. (2011). Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J. Exp. Clin. Cancer Res. 30, 41. DOI |
25 | Babbio, F., Pistore, C., Curti, L., Castiglioni, I., Kunderfranco, P., Brino, L., Oudet, P., Seiler, R., Thalman, G.N., Roggero, E., et al. (2012). The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene 31, 4878-4887. DOI |
26 | Yu, Q. (2008). Cancer gene silencing without DNA hypermethylation. Epigenetics 3, 315-317. DOI |
27 | Jeon, J.H., Lee, K.N., Hwang, C.Y., Kwon, K.S., You, K.H., and Choi, I. (2005). Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res. 65, 4485-4489. DOI |
28 | Gronbaek, K., Hother, C., and Jones, P.A. (2007). Epigenetic changes in cancer. APMIS 115, 1039-1059. DOI |
29 | Han, S.H., Jeon, J.H., Ju, H.R., Jung, U., Kim, K.Y., Yoo, H.S., Lee, Y.H., Song, K.S., Hwang, H.M., Na, Y.S., et al. (2003). VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22, 4035-4046. DOI |
30 | Hong, K., Xu, G., Grayson, T.B., and Shalev, A. (2016). Cytokines regulate beta-cell thioredoxin-interacting protein (TXNIP) via distinct mechanisms and pathways. J. Biol. Chem. 291, 8428-8439. DOI |
31 | Dunn, L.L., Buckle, A.M., Cooke, J.P., and Ng, M.K. (2010). The emerging role of the thioredoxin system in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 30, 2089-2098. DOI |
32 | Baldan, F., Mio, C., Lavarone, E., Di Loreto, C., Puglisi, F., Damante, G., and Puppin, C. (2015). Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells. Oncol. Rep. 33, 2199-2206. DOI |
33 | Barrett, T., Wilhite, S.E., Ledoux, P., Evangelista, C., Kim, I.F., Tomashevsky, M., Marshall, K.A., Phillippy, K.H., Sherman, P.M., Holko, M., et al. (2013). NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 41, D991-D995. DOI |
34 | Beck, A., Trippel, F., Wagner, A., Joppien, S., Felle, M., Vokuhl, C., Schwarzmayr, T., Strom, T.M., von Schweinitz, D., Langst, G., et al. (2018). Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. Clin. Epigenetics 10, 27. DOI |
35 | Biewenga, P., Buist, M.R., Moerland, P.D., Ver Loren van Themaat, E., van Kampen, A.H., ten Kate, F.J., and Baas, F. (2008). Gene expression in early stage cervical cancer. Gynecol. Oncol. 108, 520-526. DOI |
36 | Bostick, M., Kim, J.K., Esteve, P.O., Clark, A., Pradhan, S., and Jacobsen, S.E. (2007). UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760-1764. DOI |
37 | Dutta, K.K., Nishinaka, Y., Masutani, H., Akatsuka, S., Aung, T.T., Shirase, T., Lee, W.H., Yamada, Y., Hiai, H., Yodoi, J., et al. (2005). Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stressinduced renal carcinogenesis. Lab. Invest. 85, 798-807. DOI |
38 | El-Araby, A.M., Fouad, A.A., Hanbal, A.M., Abdelwahab, S.M., Qassem, O.M., and El-Araby, M.E. (2016). Epigenetic pathways of oncogenic viruses: therapeutic promises. Arch. Pharm. (Weinheim) 349, 73-90. DOI |
![]() |